GLOBAL GEOGRAPHY OF INFECTIVE ENDOCARDITIS PATHOGENS: ETIOLOGY AND RESISTANCE IN THE 21ST CENTURY

  • Saška Trnkić Andrejević Kladovo Health Center, Kladovo, Republic of Serbia
  • Tatjana Ristić Adult Health Care Service, Niš, Republic of Serbia
  • Dejan Čučulanović Kladovo Health Center, Kladovo, Republic of Serbia
  • Snežana Ćirić Zdravković Clinic for Cardiology, University Clinical Center Niš, Niš, Republic of Serbia
  • Desa Nastasijević Borovac Clinic for Pulmonology, University Clinical Center Niš, Niš, Republic of Serbia
Keywords: infective endocarditis, causative agents, global distribution, echocardiography

Abstract


Introduction/Aim: The etiology of infective endocarditis is diverse and complex. It varies significantly depending on geographical region, socioeconomic conditions, healthcare availability, and the prevalence of predisposing factors. The aim of this paper is to analyze the global geographical distribution of infective endocarditis pathogens in the 21st century, focusing on regional differences in etiology, diagnostics, therapy, and antimicrobial resistance.

Methods: A secondary data analysis was conducted. Descriptive statistics were used to quantify pathogen frequency, the prevalence of resistant strains, and regional etiological differences.

Results: In developed regions (North America and Western Europe), Staphylococcus aureus predominates, often associated with healthcare settings (30–35%) and high rates of MRSA resistance (up to 28%). Conversely, in developing countries, streptococci remain more prevalent, alongside the persistence of rheumatic heart disease. The availability of transesophageal echocardiography (TEE) and surgical treatment is significantly higher in developed countries, which directly contributes to a lower mortality rate (14–15%) compared to resource-limited regions (22%).

Conclusion: Infective endocarditis has evolved into a disease associated with modern medicine and aging populations in developed countries, while in the rest of the world, it remains strongly associated with low socioeconomic conditions. High mortality and increasing resistance necessitate the global standardization of diagnostics and locally adapted therapeutic strategies.

References

Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015;36(44):3075-128.

Hoen B, Duval X. Infective endocarditis. N Engl J Med. 2013;368(15):1425-33.

Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: theInternational Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169(5):463-73.

Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387(10021):882-93.

Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005;293(24):3012-21.

Slipczuk L, Codolosa JN, Davila CD, Romero-Corral A, Yun J, Pressman GS, et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS One. 2013;8(12):e82665.

Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633-8.

Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Mick MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435-86.

Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP Infective Endocarditis European Registry (EURO-ENDO). Heart. 2019;105(17):1332-9.

Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A, et al. Trends in infective endocarditis incidence, microbiology, and outcomes in the United States from 1998 to 2009. J Am Coll Cardiol. 2015;65(13):1368-76.

Thuny F, Grisoli D, Collart F, Habib G, Raoult D. Management of infective endocarditis: challenges and perspectives. Lancet. 2012;379(9819):965-75.

Klein M, Wang A. Infective endocarditis. J Intensive Care Med. 2016;31(3):151-63.

Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, et al. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med. 2008;168(19):2095-103.

Published
2026/05/29
Section
ORIGINAL ARTICLE